Insiders · Profile

BESHAR LUKE M

Director at Protara Therapeutics · Director at REGENXBIO. Filing since 19 Nov 2018. CIK 0001192128

Company
Date
Role
Action
Shares
Amount
Of holding
30 Jun 2022
Director
Bought
10,000
$31.00K
5.3%
14 Mar 2022
Director
Bought
10,000
$42.50K
5.6%
10 Mar 2022
Director
Bought
10,000
$44.56K
6.0%
29 Nov 2018
Director
Sold, plan not stated
12,784
$830.96K
100%
27 Nov 2018
Director
Sold, plan not stated
18,786
$1.22M
100%
26 Nov 2018
Director
Sold, plan not stated
1,721
$111.87K
100%
20 Nov 2018
Director
Sold, plan not stated
21,176
$1.28M
100%
19 Nov 2018
Director
Sold, plan not stated
12,116
$733.60K
100%
8 decisions on file.